tirzepatide and kidney damage (Zepbound) showed improved function in obese patients with both chronic kidney disease #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Kidney Outcomes in SURPASS: Exploring

The peptide demonstrates particular effectiveness in photo-damaged skin, reducing hyperpigmentation and UV-induced damage while improving overall skin texture and firmness

The BUD is calculated from the date of compounding, not the date of delivery or first use

The existing evidence base does not establish tirzepatide as a disease-modifying therapy for Hashimoto's thyroiditis or as a treatment that directly addresses the autoimmune pathophysiology underlying the condition

It's just good lab practice

Always consult with your doctor or qualified healthcare provider before starting any new supplement protocol, making changes to your diet, or if you have questions about a medical condition

Tirzepatide is not right for everyone